Patents by Inventor Armin Walter

Armin Walter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260096074
    Abstract: A power electronics unit for a vehicle, comprising: a housing; a boundary, which divides the housing into an interference reduction area and an interference source area, and separates the interference reduction area from the interference source area; high-voltage power electronics inside the interference source area; and a printed circuit board, at least part of which is inside the interference reduction area, wherein there is a low-voltage connection for low-voltage signals in the interference reduction area, wherein the low-voltage signals are sent to and from a higher-order system in the vehicle, and wherein there is a battery connection to the power electronics unit on the printed circuit board inside the interference reduction area. The present disclosure also relates to a vehicle that has a battery, and electric motor, and a power electronics unit.
    Type: Application
    Filed: October 1, 2025
    Publication date: April 2, 2026
    Applicant: ZF Friedrichshafen AG
    Inventors: Illia Manushyn, Claudio Pero, Thomas Spangler, Armin Walter, Andreas Schakies, Matthias Scheidel, Friedrich Bach, Jens Bachstein
  • Publication number: 20050176651
    Abstract: Tripeptide boronic acids of (R,S,R) configuration, for example Cbz-(R)-Phe-(S)-Pro-(R)-Mpg-B(OH)2, and their use to make base addition salts of such acids. The salts are formulated into anti-thrombotic pharmaceutical formulations.
    Type: Application
    Filed: September 8, 2004
    Publication date: August 11, 2005
    Inventors: David Madge, Mark Dolman, Armin Walter, Dieter Krimmer, John Deadman, Alfred Olbrich, Andrea Weiland-Waibel
  • Publication number: 20050119226
    Abstract: Organoboronic acids, for example Cbz-(R)-Phe-(S)-Pro-(R)-Mpg-B(OH)2, are made by hydrolysing their diethanolamine adducts under conditions which avoid substantial C—B bond breakage. The product acids are substantially free of degradation product derived from cleavage of the C—B bond thereof. The acids are used to make base addition salts thereof. The salts are formulated into anti-thrombotic pharmaceutical formulations.
    Type: Application
    Filed: September 8, 2004
    Publication date: June 2, 2005
    Inventors: Armin Walter, Alfred Olbrich, Andrea Weiland-Waibel, Dieter Krimmer